# PHASE 26 — HONEST SCORECARD
*No labels. No scores. Binary answers, evidence, and what's missing. Per Phase 26 spec.*

| Question | Status | Confidence | Evidence | What's Missing |
|---|---|---|---|---|
| Is the data pipeline free of lookahead bias? | **PARTIAL** | MED | `engine.py:444`, `backtest_suite.py:25` `shift(1)`, `mtf_cursor.py:49-75`, `lookahead_guard.py` | scaler-fit location, repo-wide `bfill`/`center=True`, DST handling |
| Has the backtest been validated against an independent data feed? | **NO** | HIGH | `scripts/download_duka.py` exists; no diff artifact | the actual Dukascopy comparison run |
| Is the cost model correct (units verified)? | **NO** | HIGH | `cost_model.py:43` slippage≡spread; `engine.py:726` 100× FX-major error (hand re-derived) | nothing — bug is confirmed |
| Was the previously identified cost-unit bug actually fixed? | **UNVERIFIED** | MED | only current state confirmed; no before/after diff (R13) | the prior buggy version or commit diff |
| Is same-bar SL/TP resolution conservative or tick-confirmed? | **YES** | HIGH | `execution_simulator.py:287-303,354-367`; `fill_model.py:81-84` | nothing — verified |
| Is there a statistically significant OOS edge after costs? | **NO** | HIGH | `SUMMARY.md` Net P&L −$23.21; 67 trades < 200 minimum; no corrected p-value | nothing — answer is NO |
| Is multiple-testing correction applied? | **NO** | HIGH | no corrected p-value anywhere; DSR module exists, not invoked | trial count from hypothesis log |
| Has the result survived label-shuffling / adversarial testing? | **UNVERIFIED** | HIGH | `test_label_shuffling.py` exists, never run | the run + result |
| Is the Deflated Sharpe Ratio still > 0 after correcting for all trials? | **UNVERIFIED** | HIGH | `validation/deflated_sharpe.py` exists, not run | trial count + run |
| Does the strategy survive an explicit tail-event/stress replay? | **NO** | HIGH | 7-day M1 data has no tail event (R18) | longer data containing a shock |
| Are risk limits/kill switches in code, incl. persistence across restart? | **PARTIAL** | HIGH | `kill_switch.py:30,145-155` persists ✓; order-path gate UNVERIFIED; max_positions 5 vs 1 conflict | live order-path `is_active()` check |
| Is MT5 connection failure handled safely? | **YES** | HIGH | `connection.py:88-101` verifies, `103-114` exponential-backoff reconnect | weekend-gap / requeue handling |
| Is crash-recovery / position reconciliation implemented? | **PARTIAL** | MED | `execution/reconcile.py`, `recovery.py`, `canary/position_reconciler.py` exist | boot-time call-site |
| Are credentials/secrets properly secured? | **PARTIAL** | HIGH | NOT in git history ✓; but ALL plaintext in `.env` on disk; `postgres:postgres` DB | host/VPS hardening; secrets manager |
| Would a silent system failure be detected? | **PARTIAL** | MED | in-process DMS 300s, Telegram alerts, tamper ledger | no disk/mem monitor; DMS in-process ≠ crash-safe |
| Is backtest/live code parity confirmed? | **NO** | HIGH | three paths; backtest `strategies/*` ≠ live `regime/*` ≠ suite inline | a single shared feature fn |
| Is the codebase safe to extend without breaking parity? | **NO** | MED | parity already broken; 53 files ≥500 LOC; duplicated logic | refactoring plan |
| Is the research methodology reproducible? | **PARTIAL** | MED | `LookaheadGuard`, frozen `RiskPolicy`; but `test_label_shuffling.py` no seed; no data versioning | repo-wide seed audit; data manifest lock |
| Is the capacity ceiling above the capital intended to be deployed? | **UNVERIFIED** | HIGH | not computed | the capacity/slippage-curve run |
| Is the broker's regulatory/counterparty status confirmed safe? | **UNVERIFIED** | HIGH | broker identity ambiguous (3 servers); Pepperstone TOS not checked | broker public disclosures |
| Is there a pre-committed live statistical stopping rule? | **NO** | HIGH | no SPRT/CUSUM in code | implementation |
| Could someone other than the developer safely operate/halt this from docs alone? | **UNVERIFIED** | MED | `reports/RUNBOOK.md` exists | completeness review by a third party |
| Is this system ready for paper trading? | **NO** | HIGH | Phase 25: 5 hard NOs (cost, parity, label-shuffle, edge, feed-xval) | resolving items 3,6,11 + feed xval |
| Is this system ready for real capital? | **NO** | HIGH | Phase 25: majority NO/UNVERIFIED | the entire Live Capital Gate |
| **Go/No-Go classification (Phase 24)** | **see below** | MED | evidence in Phases 3,7,8,13 | full Phase 24 writeup (Tier 2) |

**Phase 24 classification (preliminary, pending full Phase 24):**
Given (a) no cost-adjusted OOS edge in any artifact, (b) the live system trades a *different* strategy stack than the backtest, (c) the headline `results/*.json` is an uncosted bar-return artifact, and (d) the only costed run was net-negative on 67 trades — **the evidence does not support CONTINUE-SAME-APPROACH.** The classification leans **STOP or PIVOT** but the full Phase 24 (Tier 2) must state the specific pivot rationale and the trial count. Stated honestly: today the correct answer is **STOP (no confirmed edge), pending the cheapest possible disambiguation — run the label-shuffle test.**

---

## Scorecard — Plain-English Summary

**Verified YES (real strengths, not flattery):**
1. Same-bar SL/TP is conservative-by-default (R17) — genuinely well-built.
2. Secrets are NOT in git history — passed the hardest security check.
3. Kill switch persists across restart at the storage layer.
4. MT5 reconnect is real (verifies + exponential backoff).
5. Trade ledger is tamper-evident with rich per-trade provenance.
6. Lookahead is well-defended in the audited hot paths.

**Verified NO / FAIL (hard truths):**
1. **No statistically significant cost-adjusted OOS edge exists** — the project's own `SUMMARY.md` reports a net loss.
2. **Backtest and live trade different strategy code** — parity is broken.
3. **Cost model has confirmed unit bugs** (slippage≡spread; 100× FX-major error).
4. **Headline `results/*.json` is an uncosted bar-return artifact** — non-tradeable.
5. **The label-shuffle test was built but never run** — P0.
6. **7-day M1 data** — no tail-event survival claim is possible (R18).
7. **No multiple-testing correction, no DSR/PBO run, no capacity ceiling, no Kelly derivation.**

**The honest one-sentence truth:** This is a well-engineered *infrastructure* with genuinely strong safety primitives, attached to a *strategy* that has not yet demonstrated an edge — and the cheapest test that could confirm or refute an edge has, inexplicably, never been run.
